查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1675235

2025年酵素全球市场报告

Enzymes Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年酶的市场规模将快速成长。到 2029 年，这一数字将成长至 258.8 亿美元，复合年增长率为 14.0%。预测期内的成长归因于市场需求动态、对永续实践、健康和营养趋势、生质燃料和可再生能源以及新兴应用的关注。预测期内的关键趋势包括生物技术的进步、永续性的需求、食品和饮料行业的需求、不断扩大的工业应用以及消费者对天然产品的偏好。

由于消化器官系统疾病的盛行率不断上升，酵素市场预计将会成长。这些影响消化器官系统的疾病包括胃食道逆流症 (GERD)、癌症、大肠激躁症(IBS)、乳糖不耐症、食道裂孔疝气和胆结石等。消化器官系统中的酵素在将食物分解成可吸收的分子方面发挥着至关重要的作用。根据美国生物技术资讯中心 (NCBI) 的数据，截至 2022 年 10 月，美国大肠激躁症(IBS) 的盛行率为 10%-15%，其中近 12% 的患者在初级保健机构中寻求与 IBS 相关的医疗照护。此类消化器官系统疾病的增加促进了酵素市场的成长。

癌症发生率的不断上升使得化疗中必须使用药物代谢酶 (DME)，预计这将推动酶市场的发展。这些酵素在体内变得活跃并破坏癌细胞，摧毁肿瘤。癌症患者肿瘤组织和代谢器官中药物代谢酶（DME）的表达和功能对于抗癌药物和化疗反应不佳的患者至关重要。根据美国癌症协会的《2022 年癌症事实与数据》报告，美国2022 年预计将新增 190 万例癌症病例，高于 2020 年报告的 180 万例。同时，预计 2022 年癌症死亡人数为 609,360 人，而 2021 年为 608,570 人，比 2021 年略有增加。可透过酵素疗法治疗的癌症盛行率不断上升，预计将推动酵素市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治、新冠疫情和市场復苏的影响

第五章 全球成长分析与策略分析框架

  • 世界酵素PESTEL分析（政治、社会、科技、环境、法律因素、促进因素、抑制因素）
  • 最终用途产业分析
  • 全球酵素市场：增长率分析
  • 全球酵素市场表现：规模与成长，2019-2024
  • 全球酵素市场预测：规模与成长，2024-2029 年，2034 年
  • 全球酵素总目标市场（TAM）

第六章市场区隔

  • 全球酵素市场：按产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 天冬胺酶
  • 脂肪酶
  • 蛋白酶
  • 纳豆激酶
  • 几丁质酶
  • 舍雷肽酶
  • 胶原酶
  • 连接酶
  • 其他产品
  • 全球酵素市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 白血病
  • 胃病
  • 抗肿瘤
  • 皮肤溃疡
  • 高雪氏症
  • 法布瑞氏症
  • 其他用途
  • 全球酵素市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药商
  • 医院
  • 私人诊所
  • 研究部门
  • 全球酵素市场Asparaginase细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • L-Asparaginase
  • 欧文氏菌天Asparaginase
  • 聚乙二醇化天冬Asparaginase
  • 全球酵素市场脂肪酶细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 胃脂肪酶
  • 胰脂肪酶
  • 真菌脂肪酶
  • 细菌脂肪酶
  • 全球酵素市场、蛋白酶细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 丝胺酸蛋白酶
  • 半胱氨酸蛋白酶
  • 天门冬胺酸蛋白酶
  • 金属蛋白酶
  • 全球酵素市场纳豆激酶细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 纳豆激酶粉
  • 纳豆激酶胶囊
  • 全球酵素市场几丁质酶细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 植物几丁质酶
  • 微生物几丁质酶
  • 全球酵素市场 Serratiopeptidase 细分市场、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 舍雷肽酶片
  • 舍雷肽酶胶囊
  • 全球酵素市场胶原酶细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • I型胶原蛋白酶
  • II型胶原蛋白酶
  • III型胶原蛋白酶
  • 全球酵素市场、连接酶细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • DNA连接酶
  • RNA连接酶
  • 全球酵素市场、其他产品细分、按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 淀粉酶
  • 纤维素酶
  • β-葡聚醣酶
  • 其他特种酶

第七章 区域和国家分析

  • 全球酵素市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球酵素市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 酵素市场：竞争格局
  • 酵素市场：公司简介
    • Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
    • DuPont Industrial Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis
    • Chr. Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Roche Holding AG
  • Advanced Enzyme Technologies Ltd.
  • AB Enzymes GmbH
  • Codexis Inc.
  • Dyadic International Inc.
  • Amano Enzyme Inc.
  • Adisseo France SAS
  • Biocatalysts Ltd.
  • Amano Enzyme Inc.（duplicate）
  • Enzyme Development Corporation
  • Creative Enzymes
  • Hayashibara Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Associated British Foods Plc
  • Lonza Group AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年酵素市场：提供新机会的国家
  • 2029 年酵素市场：细分领域带来新机会
  • 2029 年酵素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r26427

An enzyme is a protein that typically functions as a biological catalyst. It speeds up specific chemical reactions within cells. Enzymes are substances that act as catalysts in living organisms, regulating the rate of chemical processes without being altered themselves.

Various enzyme product types include asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. Protease, for instance, catalyzes proteolysis, breaking down proteins into smaller polypeptides or individual amino acids while facilitating the creation of new protein products. These enzymes find application in treating conditions such as leukemia, stomach disorders, antitumor therapies, skin ulcers, Gaucher disease, Fabry disease, among others. They are utilized by drug manufacturers, hospitals, private clinics, and research laboratories.

The enzymes market research report is one of a series of new reports from The Business Research Company that provides enzymes market statistics, including enzymes industry global market size, regional shares, competitors with an enzymes market share, detailed enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the enzymes industry. This enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzymes market size has grown rapidly in recent years. It will grow from $13.38 billion in 2024 to $15.33 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to globalization and market expansion, research and development investments, consumer awareness and demand, bioprocessing technology improvements, waste reduction and recycling.

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $25.88 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to market demand dynamics, focus on sustainable practices, health and nutrition trends, biofuel and renewable energy, emerging applications. Major trends in the forecast period include biotechnology advancements, sustainability demands, food and beverage industry demand, industrial applications expansion, consumer preference for natural products.

The enzyme market is anticipated to experience growth driven by an increase in the prevalence of digestive disorders. These disorders, impacting the digestive system, encompass conditions such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes play a crucial role in breaking down food into absorbable molecules. As of October 2022, the National Center for Biotechnology Information (NCBI) reports that the prevalence of irritable bowel syndrome (IBS) in the United States ranges between 10% and 15%, with nearly 12% of patients seeking medical care for IBS-related concerns in primary care practices. This rise in digestive disorders contributes to the growth of the enzyme market.

The enzyme market is expected to be fueled by the increasing prevalence of cancer, necessitating the use of drug-metabolizing enzymes (DMEs) for chemotherapy. These enzymes activate within the body to destroy cancer cells and break down tumors. The expression and functionality of drug-metabolizing enzymes (DMEs) in the tumor tissues and metabolic organs of cancer patients are crucial for those with a low response to anticancer drugs and chemotherapy. The Cancer Facts and Figures 2022 report by the American Cancer Society indicates an estimated 1.9 million new cancer cases in the United States in 2022, reflecting an increase from the 1.8 million reported in 2020. While the estimated number of cancer deaths in 2022 is slightly higher than in 2021, with 609,360 projected deaths compared to 608,570 in 2021. The rising prevalence of cancer treatable with therapeutic enzymes is anticipated to propel the growth of the enzyme market.

Leading companies in the enzyme market are focusing on innovation by developing advanced products such as Lamzede, catering to the needs of patients. Lamzede (velmanase alfa) is a pharmaceutical product designed for the treatment of alpha-mannosidosis, a rare genetic disorder characterized by insufficient activity of the lysosomal alpha-galactosidase-A enzyme. In a noteworthy development in May 2023, Chiesi Global Rare Diseases, a pharmaceutical manufacturing company based in the United States, obtained FDA approval for Lamzede (velmanase alfa). This approval pertains to the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede represents a recombinant form of human alpha-mannosidase, developed using recombinant DNA technology in mammalian Chinese hamster ovary (CHO) cells. It stands out as the first enzyme replacement therapy sanctioned in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.

A notable trend gaining prominence in the enzymes market is the exploration of novel approaches for cancer treatment utilizing enzymes. Substantial investments in research by major universities and companies aim to advance enzyme therapies for combating cancer. In another significant development in May 2023, Chiesi Global Rare Diseases secured FDA approval for ELFABRIO (pegunigalsidase alfa-iwxj), designed to address Fabry disease. This rare genetic disorder is characterized by insufficient activity of the lysosomal a-galactosidase-A enzyme, leading to the progressive accumulation of globotriaosylceramide (Gb3) in blood vessel walls throughout the body. ELFABRIO (pegunigalsidase alfa-iwxj) stands out as a PEGylated enzyme replacement therapy (ERT).

In February 2023, AstraZeneca, a U.S.-based pharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.3 billion. This strategic move is set to strengthen AstraZeneca's cardiorenal pipeline through the incorporation of CinCor's candidate drug, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) designed for lowering blood pressure in individuals with treatment-resistant hypertension. CinCor Pharma Inc., the acquired biotechnology company, is based in the United States and is focused on the development of enzyme-based therapeutics.

Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Other Products
  • 2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Other Applications
  • 3) By End User: Drug Manufacturers; Hospitals; Private Clinics; Research Laboratories
  • Subsegments:
  • 1) By Asparaginase: L-asparaginase; Erwinia Asparaginase; Pegylated Asparaginase
  • 2) By Lipase: Gastric Lipase; Pancreatic Lipase; Fungal Lipase; Bacterial Lipase
  • 3) By Protease: Serine Proteases; Cysteine Proteases; Aspartic Proteases; Metalloproteases
  • 4) By Nattokinase: Nattokinase Powder; Nattokinase Capsules
  • 5) By Chitinase: Plant Chitinase; Microbial Chitinase
  • 6) By Serratiopeptidase: Serratiopeptidase Tablets; Serratiopeptidase Capsules
  • 7) By Collagenase: Type I Collagenase; Type II Collagenase; Type III Collagenase
  • 8) By Ligase: DNA Ligase; RNA Ligase
  • 9) By Other Products: Amylase; Cellulase; Beta-Glucanase; Other Specialty Enzymes
  • Companies Mentioned: Novozymes A/S; DuPont Industrial Biosciences; BASF SE; Koninklijke DSM N.V.; Chr. Hansen Holding A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzymes Market Characteristics

3. Enzymes Market Trends And Strategies

4. Enzymes Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Enzymes Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Enzymes Market Growth Rate Analysis
  • 5.4. Global Enzymes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Enzymes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Enzymes Total Addressable Market (TAM)

6. Enzymes Market Segmentation

  • 6.1. Global Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asparginase
  • Lipase
  • Protease
  • Nattokinase
  • Chitinase
  • Serratiopeptidase
  • Collagenase
  • Ligase
  • Other Products
  • 6.2. Global Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukemia
  • Stomach Disorders
  • Antitumor
  • Skin Ulcers
  • Gaucher Disease
  • Fabry Disease
  • Other Applications
  • 6.3. Global Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Manufacturers
  • Hospitals
  • Private Clinics
  • Research Laboratories
  • 6.4. Global Enzymes Market, Sub-Segmentation Of Asparaginase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • L-asparaginase
  • Erwinia Asparaginase
  • Pegylated Asparaginase
  • 6.5. Global Enzymes Market, Sub-Segmentation Of Lipase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastric Lipase
  • Pancreatic Lipase
  • Fungal Lipase
  • Bacterial Lipase
  • 6.6. Global Enzymes Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serine Proteases
  • Cysteine Proteases
  • Aspartic Proteases
  • Metalloproteases
  • 6.7. Global Enzymes Market, Sub-Segmentation Of Nattokinase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nattokinase Powder
  • Nattokinase Capsules
  • 6.8. Global Enzymes Market, Sub-Segmentation Of Chitinase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant Chitinase
  • Microbial Chitinase
  • 6.9. Global Enzymes Market, Sub-Segmentation Of Serratiopeptidase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serratiopeptidase Tablets
  • Serratiopeptidase Capsules
  • 6.10. Global Enzymes Market, Sub-Segmentation Of Collagenase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type I Collagenase
  • Type II Collagenase
  • Type III Collagenase
  • 6.11. Global Enzymes Market, Sub-Segmentation Of Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Ligase
  • RNA Ligase
  • 6.12. Global Enzymes Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amylase
  • Cellulase
  • Beta-Glucanase
  • Other Specialty Enzymes

7. Enzymes Market Regional And Country Analysis

  • 7.1. Global Enzymes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Enzymes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzymes Market

  • 8.1. Asia-Pacific Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzymes Market

  • 9.1. China Enzymes Market Overview
  • 9.2. China Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzymes Market

  • 10.1. India Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzymes Market

  • 11.1. Japan Enzymes Market Overview
  • 11.2. Japan Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzymes Market

  • 12.1. Australia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzymes Market

  • 13.1. Indonesia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzymes Market

  • 14.1. South Korea Enzymes Market Overview
  • 14.2. South Korea Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzymes Market

  • 15.1. Western Europe Enzymes Market Overview
  • 15.2. Western Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzymes Market

  • 16.1. UK Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzymes Market

  • 17.1. Germany Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzymes Market

  • 18.1. France Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzymes Market

  • 19.1. Italy Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzymes Market

  • 20.1. Spain Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzymes Market

  • 21.1. Eastern Europe Enzymes Market Overview
  • 21.2. Eastern Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzymes Market

  • 22.1. Russia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzymes Market

  • 23.1. North America Enzymes Market Overview
  • 23.2. North America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzymes Market

  • 24.1. USA Enzymes Market Overview
  • 24.2. USA Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzymes Market

  • 25.1. Canada Enzymes Market Overview
  • 25.2. Canada Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzymes Market

  • 26.1. South America Enzymes Market Overview
  • 26.2. South America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzymes Market

  • 27.1. Brazil Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzymes Market

  • 28.1. Middle East Enzymes Market Overview
  • 28.2. Middle East Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzymes Market

  • 29.1. Africa Enzymes Market Overview
  • 29.2. Africa Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Enzymes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Enzymes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzymes Market Competitive Landscape And Company Profiles

  • 30.1. Enzymes Market Competitive Landscape
  • 30.2. Enzymes Market Company Profiles
    • 30.2.1. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. DuPont Industrial Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke DSM N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Chr. Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

31. Enzymes Market Other Major And Innovative Companies

  • 31.1. Roche Holding AG
  • 31.2. Advanced Enzyme Technologies Ltd.
  • 31.3. AB Enzymes GmbH
  • 31.4. Codexis Inc.
  • 31.5. Dyadic International Inc.
  • 31.6. Amano Enzyme Inc.
  • 31.7. Adisseo France SAS
  • 31.8. Biocatalysts Ltd.
  • 31.9. Amano Enzyme Inc. (duplicate)
  • 31.10. Enzyme Development Corporation
  • 31.11. Creative Enzymes
  • 31.12. Hayashibara Co. Ltd.
  • 31.13. Thermo Fisher Scientific Inc.
  • 31.14. Associated British Foods Plc
  • 31.15. Lonza Group AG

32. Global Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzymes Market

34. Recent Developments In The Enzymes Market

35. Enzymes Market High Potential Countries, Segments and Strategies

  • 35.1 Enzymes Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Enzymes Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Enzymes Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer